CLINICAL TRIALS PROFILE FOR BENDROFLUMETHIAZIDE; NADOLOL
✉ Email this page to a colleague
All Clinical Trials for bendroflumethiazide; nadolol
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00647660 ↗ | Fasting Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg | Completed | Mylan Pharmaceuticals | Phase 1 | 2006-07-01 | The objective of this study was to investigate the bioequivalence of Mylan's nadolol/bendroflumethiazide 80 mg/5 mg tablets to King's Corzide® 80 mg/5 mg tablets following a single, oral 80 mg/5 mg (1 x 80 mg/5 mg) dose administered under fasting conditions. |
| NCT00648297 ↗ | Fed Study of Nadolol/Bendroflumethiazide Tablets 80 mg/5 mg and Corzide® Tablets 80 mg/5 mg | Completed | Mylan Pharmaceuticals | Phase 1 | 2006-08-01 | The objective of this study was to investigate the bioequivalence of Mylan's nadolol/bendroflumethiazide 80 mg/5 mg tablets to King's Corzide® 80 mg/5 mg tablets following a single, oral 80 mg/5 mg (1 x 80 mg/5 mg) dose administered under fed conditions. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for bendroflumethiazide; nadolol
Condition Name
Clinical Trial Locations for bendroflumethiazide; nadolol
Trials by Country
Clinical Trial Progress for bendroflumethiazide; nadolol
Clinical Trial Phase
Clinical Trial Sponsors for bendroflumethiazide; nadolol
Sponsor Name
